Brugesicp 400 mg/325 mg Tablet
By Brugesicp
Rx
15 Tablet in a Strip

Composition
Ibuprofen(400mg) + Paracetamol(325mg)

Manufacturer - Biochem Pharmaceutical Industries
BIOCHEM PHARMA, LG 113 / A, Xth Central Mall, Mahavir Nagar, 90ft Road, Next to D Mart, Kandivali - West, Mumbai - 400067.

Expires on or after
September, 2025

liver
Brugesicp 400 mg/325 mg Tablet needs to be used carefully in individuals with liver disease. It may be necessary to adjust the dosage of Brugesicp 400 mg/325 mg Tablet in such cases, so it's important to consult your doctor. However, people with severe liver disease or active liver disease are advised against using Brugesicp 400 mg/325 mg Tablet.

kidney
Brugesicp 400 mg/325 mg Tablet should be used cautiously in patients with kidney disease. Consult your doctor for possible dose adjustment. Avoid in severe kidney disease. Prolonged use may impact kidney function.

alcohol
It is not safe to drink alcohol while taking Brugesicp 400 mg/325 mg Tablet.

driving
Brugesicp 400 mg/325 mg Tablet may reduce alertness, impact vision, cause drowsiness, and dizziness. Avoid driving if experiencing these effects.

pregnancy
Brugesicp 400 mg/325 mg Tablet may not be safe during pregnancy. Animal studies suggest potential harm to the unborn baby. Your doctor will evaluate the risks and benefits before prescribing. Kindly seek your doctor's advice.

breastfeeding
Brugesicp 400 mg/325 mg Tablet is considered safe for breastfeeding. Research shows minimal transfer to breastmilk and no harm to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | PAIN ANALGESICS |
Action Class | - |
₹11.92
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 18-Nov-2024